Search stocks

Find any stock by ticker or company name

Home

TRVI

Trevi Therapeutics, Inc. (TRVI)

NGM – Real vaqt narxi. Valyuta: USD

17.67

-0.14 (-0.76%)

Bozor ochiq: Aug 12, 2026, 2:24 PM EDT

17.80

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Kuzatuv
Bozorlar
Kalendar
Skriner
Yangiliklar
Biz haqimizda

TRVI - Trevi Therapeutics, Inc. So'nggi... | Finranks

Home

TRVI

Trevi Therapeutics, Inc. (TRVI)

NGM – Real vaqt narxi. Valyuta: USD

17.67

-0.14 (-0.76%)

Bozor ochiq: Aug 12, 2026, 2:24 PM EDT

17.80

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

07.08.2026

Trevi Therapeutics Q2 Earnings Call Highlights

Trevi Therapeutics NASDAQ: TRVI said it began two clinical trials during the second quarter and plans to launch a third study in the third quarter as it advances nalbuphine ER, also known as Haduvio, for multiple chronic-cough indications.

06.08.2026

Trevi Therapeutics, Inc. (TRVI) Q2 2026 Earnings Call Transcript

06.08.2026

Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates

Initiated Phase 3 OCEAN-1 trial for patients with idiopathic pulmonary fibrosis-related chronic cough in the second quarter; Phase 3 OCEAN-2 trial expected to initiate in the third quarter of 2026

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates

Initiated Phase 3 OCEAN-1 trial for patients with idiopathic pulmonary fibrosis-related chronic cough in the second quarter; Phase 3 OCEAN-2 trial expected to initiate in the third quarter of 2026